Rajamma Mathew

1.4k total citations
43 papers, 1.1k citations indexed

About

Rajamma Mathew is a scholar working on Pulmonary and Respiratory Medicine, Cell Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rajamma Mathew has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 16 papers in Cell Biology and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rajamma Mathew's work include Pulmonary Hypertension Research and Treatments (24 papers), Caveolin-1 and cellular processes (16 papers) and Cardiovascular Function and Risk Factors (6 papers). Rajamma Mathew is often cited by papers focused on Pulmonary Hypertension Research and Treatments (24 papers), Caveolin-1 and cellular processes (16 papers) and Cardiovascular Function and Risk Factors (6 papers). Rajamma Mathew collaborates with scholars based in United States, Hungary and Germany. Rajamma Mathew's co-authors include Michael H. Gewitz, Jing Huang, Jing Huang, Michael S. Wolin, Susan C. Olson, Joseph Wu, Burton M. Altura, Kirit Patel, Pravin B. Sehgal and Sachin A. Gupte and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PEDIATRICS.

In The Last Decade

Rajamma Mathew

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajamma Mathew United States 20 648 390 304 241 214 43 1.1k
Megha Talati United States 21 1.1k 1.8× 451 1.2× 550 1.8× 85 0.4× 195 0.9× 34 1.6k
Saeid Babaei Canada 10 170 0.3× 389 1.0× 177 0.6× 68 0.3× 232 1.1× 11 855
Xuefei Tian United States 20 223 0.3× 496 1.3× 92 0.3× 134 0.6× 79 0.4× 60 1.1k
Fares A. Masri United States 6 596 0.9× 325 0.8× 222 0.7× 31 0.1× 147 0.7× 8 817
Erik Morrow United States 6 466 0.7× 811 2.1× 272 0.9× 49 0.2× 151 0.7× 6 1.2k
Imad Al Ghouleh United States 15 258 0.4× 425 1.1× 145 0.5× 45 0.2× 330 1.5× 30 1.0k
Yong-Hu Fang United States 7 856 1.3× 595 1.5× 547 1.8× 29 0.1× 141 0.7× 8 1.4k
Shinichiro Sunamura Japan 15 268 0.4× 418 1.1× 293 1.0× 45 0.2× 105 0.5× 27 956
Tadashi Kuroda Japan 13 123 0.2× 304 0.8× 489 1.6× 136 0.6× 85 0.4× 18 956
Folke Schmidt Germany 12 611 0.9× 612 1.6× 602 2.0× 30 0.1× 192 0.9× 18 1.9k

Countries citing papers authored by Rajamma Mathew

Since Specialization
Citations

This map shows the geographic impact of Rajamma Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajamma Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajamma Mathew more than expected).

Fields of papers citing papers by Rajamma Mathew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajamma Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajamma Mathew. The network helps show where Rajamma Mathew may publish in the future.

Co-authorship network of co-authors of Rajamma Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Rajamma Mathew. A scholar is included among the top collaborators of Rajamma Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajamma Mathew. Rajamma Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathew, Rajamma, Francesca Cendali, Angelo D’Alessandro, et al.. (2024). G6pd N126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker‐Induced Pulmonary Vascular Disease. Journal of the American Heart Association. 13(19). e035174–e035174. 4 indexed citations
2.
Mathew, Rajamma, et al.. (2023). Metabolic Deregulation in Pulmonary Hypertension. Current Issues in Molecular Biology. 45(6). 4850–4874. 4 indexed citations
3.
Mathew, Rajamma. (2021). Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension. SHILAP Revista de lepidopterología. 9(4). 58–58. 18 indexed citations
4.
Huang, Jing & Rajamma Mathew. (2019). Loss of cavin1 and expression of p-caveolin-1 in pulmonary hypertension: Possible role in neointima formation. 9(2). 17–29. 4 indexed citations
5.
Mathew, Rajamma, Jing Huang, Joseph Wu, John T. Fallon, & Michael H. Gewitz. (2016). Hematological disorders and pulmonary hypertension. World Journal of Cardiology. 8(12). 703–703. 40 indexed citations
6.
Abellar, Rosanna, David M. Otterburn, Rajamma Mathew, & Oliver J. Muensterer. (2015). Pulmonary Agenesis and Associated Pulmonary Hypertension: A Case Report and Review on Variability, Therapy, and Outcome. SHILAP Revista de lepidopterología. 3(1). 33–39. 9 indexed citations
7.
8.
Mathew, Rajamma. (2011). Pulmonary Hypertension: Current Therapy and Future Prospects. Cardiovascular & Hematological Agents in Medicinal Chemistry. 9(3). 165–182. 9 indexed citations
9.
Mathew, Rajamma, et al.. (2010). Immunosuppressant-induced Endothelial Damage and Pulmonary Arterial Hypertension. Journal of Pediatric Hematology/Oncology. 33(1). 55–58. 23 indexed citations
10.
Huang, Jing, et al.. (2010). Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension. Experimental Lung Research. 36(1). 57–66. 39 indexed citations
11.
Mathew, Rajamma. (2010). Inflammation and Pulmonary Hypertension. Cardiology in Review. 18(2). 67–72. 28 indexed citations
12.
Csiszár, Anna, Nazar Labinskyy, Susan C. Olson, et al.. (2009). Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats. Hypertension. 54(3). 668–675. 174 indexed citations
13.
Gupte, Sachin A., Pawel M. Kaminski, Susan C. Olson, et al.. (2009). Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction. American Journal of Physiology-Heart and Circulatory Physiology. 296(4). H1048–H1057. 50 indexed citations
14.
Huang, Jing, Pawel M. Kaminski, John G. Edwards, et al.. (2008). Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 294(6). L1250–L1259. 55 indexed citations
15.
Mathew, Rajamma, Jing Huang, & Michael H. Gewitz. (2007). Pulmonary Artery Hypertension. Cardiology in Review. 15(3). 143–149. 40 indexed citations
16.
Mathew, Rajamma, Jing Huang, Xiangmin Zhao, Susan C. Olson, & Michael H. Gewitz. (2007). Activation of signal transducer and activator of transcription (STAT) 3 in hypoxia‐induced pulmonary hypertension. The FASEB Journal. 21(6). 2 indexed citations
17.
Mathew, Rajamma, et al.. (2002). Effects of Monocrotaline on Endothelial Nitric Oxide Synthase Expression and Sulfhydryl Levels in Rat Lungs. PubMed. 4(3). 152–158. 25 indexed citations
18.
Mathew, Rajamma, Hatim Α. Omar, Weiqun Shen, et al.. (1996). Modulation by atrial natriuretic factor of receptor‐mediated cyclic AMP‐dependent responses in canine pulmonary artery during heart failure. British Journal of Pharmacology. 118(8). 1886–1890. 1 indexed citations
19.
Mathew, Rajamma, et al.. (1990). Effect of Verapamil on Monocrotaline-Induced Pulmonary Artery Hypertension and Endothelial Cell Dysfunction in Rats. Experimental Lung Research. 16(6). 627–644. 12 indexed citations
20.
Mathew, Rajamma, Otto G. Thilenius, & René A. Arcilla. (1976). Comparative response of right and left ventricles to volume overload. The American Journal of Cardiology. 38(2). 209–217. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megha Talati Breakdown of academic impact, for papers by Saeid Babaei Breakdown of academic impact, for papers by Xuefei Tian Breakdown of academic impact, for papers by Fares A. Masri Breakdown of academic impact, for papers by Erik Morrow Breakdown of academic impact, for papers by Imad Al Ghouleh Breakdown of academic impact, for papers by Yong-Hu Fang Breakdown of academic impact, for papers by Shinichiro Sunamura Breakdown of academic impact, for papers by Tadashi Kuroda Breakdown of academic impact, for papers by Folke Schmidt
Rankless by CCL
2026